...
首页> 外文期刊>BMC Public Health >Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia: a cross-sectional and population-based cohort analysis
【24h】

Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia: a cross-sectional and population-based cohort analysis

机译:在澳大利亚新南威尔士州,以液体为基础的细胞学作为常规细胞学的辅助手段进行宫颈筛查:基于群体和群体的横断面分析

获取原文
           

摘要

Background Cervical screening is currently recommended every two years in sexually active women aged 18-20 to 69?years in Australia. Direct replacement of conventional cytology with liquid-based cytology (LBC) for cervical screening was rejected for public funding on grounds of cost-effectiveness, first in 2002 and again in 2009, but LBC is performed as an adjunct to conventional cytology in women who elect to pay. The objective of this study was to describe prevalence and predictors of use of LBC in Australia’s most populous state, New South Wales (NSW). Methods We performed cross-sectional and population-based cohort analyses using data from the state Pap Test Register in NSW. We calculated the age-adjusted proportion of women aged 20-69?years electing to have adjunctive LBC over the period from 2006-2010. We also calculated the fully-adjusted odds ratios for the association between subsequent LBC use and age, socioeconomic status, place of residence, previous cytological history and provider type in a cohort of 360,247 women who had an index cervical cytology test in 2006–8. Results Uptake of LBC varied between 29.7% (95% Confidence Interval (CI): 29.5-30.0%) in 2006/7 and 26.6% (95% CI: 26.4-26.9%) in 2009/10. LBC was more likely to be used in women aged 30-44?years, if it had been used previously (OR13.58, 95% CI: 13.33-13.84), if the previous test result was abnormal (OR2.62, 95% CI:2.53-2.72) or unsatisfactory (OR2.37, 95% CI:2.27-3.47), or if a gynaecologist requested the test (OR1.50, 95% CI:1.46-1.54). Uptake was least for women in remote/very remote areas (OR0.68; 95% CI:0.57-0.80 referenced to those in major cities) and in lower socioeconomic groups (OR 0.41, 95% CI:0.40-0.42 for lowest versus highest SES quintile). Conclusion In the current environment in NSW, Australia, in which public funding for LBC has not been available, adjunctive uptake of LBC depends strongly on a woman’s age, her screening history and socioeconomic factors. These findings provide important context for a current review of technologies used in the National Cervical Screening Program in Australia.
机译:背景技术在澳大利亚,目前建议每两年对18-20至69岁的性活跃女性进行宫颈筛查。出于成本效益的考虑,最初在2002年和2009年再次以成本效益为由拒绝使用液体基细胞学(LBC)直接替代传统细胞学进行宫颈癌筛查,但由于成本效益,公共资金被拒绝,但是LBC是女性的传统细胞学的辅助手段支付。这项研究的目的是描述在澳大利亚人口最多的州新南威尔士州(NSW),LBC的使用率和预测因素。方法我们使用来自新南威尔士州状态子宫颈抹片检查寄存器的数据进行了横断面和基于人群的队列分析。我们计算了2006-2010年期间选择辅助LBC的20-69岁女性的年龄调整比例。我们还计算了2006-8期间接受索引宫颈细胞学检查的360,247名女性队列中,随后的LBC使用与年龄,社会经济地位,居住地,以前的细胞学历史和提供者类型之间的关联的完全调整后的优势比。结果2006/7年LBC摄入量在29.7%(95%置信区间(CI):29.5-30.0%)和2009/10年26.6%(95%CI:26.4-26.9%)之间变化。如果先前曾使用过LBC(OR13.58,95%CI:13.33-13.84),如果先前的检查结果不正常(OR2.62,95%),则更可能用于30-44岁的女性。 CI:2.53-2.72)或令人满意(OR2.37,95%CI:2.27-3.47),或者如果妇科医生要求进行测试(OR1.50,95%CI:1.46-1.54)。偏远/非常偏远地区(OR0.68; 95%CI:0.57-0.80,相对于主要城市的女性)和社会经济地位较低的人群(OR 0.41,95%CI:0.40-0.42,最低与最高)的女性摄入量最少SES五分之一)。结论在澳大利亚新南威尔士州当前的环境中,尚无用于LBC的公共资金,LBC的辅助摄取在很大程度上取决于妇女的年龄,她的筛查历史和社会经济因素。这些发现为当前对澳大利亚国家宫颈筛查计划中使用的技术进行回顾提供了重要的背景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号